Advanced search
Publication Cover
Pragmatic and Observational Research Volume 8, 2017 - Issue
Submit an article Journal homepage
134
Views
17
CrossRef citations to date
0
Altmetric
Review

The Salford Lung Study: a pioneering comparative effectiveness approach to COPD and asthma in clinical trials

Timothy E Albertson1 Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, School of Medicine, University of California, Davis, Sacramento;2 Department of Medicine, Veterans Administration Northern California Healthcare System, Mather;3 Department of Emergency Medicine, School of Medicine, University of California, Davis, Sacramento, CA, USACorrespondence[email protected]
,
Susan Murin1 Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, School of Medicine, University of California, Davis, Sacramento;2 Department of Medicine, Veterans Administration Northern California Healthcare System, Mather
,
Mark E Sutter2 Department of Medicine, Veterans Administration Northern California Healthcare System, Mather;3 Department of Emergency Medicine, School of Medicine, University of California, Davis, Sacramento, CA, USA
&
James A Chenoweth2 Department of Medicine, Veterans Administration Northern California Healthcare System, Mather;3 Department of Emergency Medicine, School of Medicine, University of California, Davis, Sacramento, CA, USA
Pages 175-181 | Published online: 20 Sep 2017

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

David MG Halpin, Robyn Kendall, Soham Shukla, Alan Martin, Dhvani Shah, Dawn Midwinter, Kai M Beeh, Janwillem WH Kocks, Paul W Jones, Chris Compton, Nancy A Risebrough & Afisi S Ismaila. (2022) Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2745-2755.
Read now
Timothy E. Albertson, James A. Chenoweth, Skyler J. Pearson & Susan Murin. (2020) The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS). Expert Opinion on Pharmacotherapy 21:2, pages 213-231.
Read now

Articles from other publishers (15)

Jing Liu, Jeffrey S. Barrett, Efthimia T. Leonardi, Lucy Lee, Satrajit Roychoudhury, Yong Chen & Panayiota Trifillis. (2022) Natural History and Real‐World Data in Rare Diseases: Applications, Limitations, and Future Perspectives. The Journal of Clinical Pharmacology 62:S2.
Crossref
Afisi S. Ismaila, Katrin Haeussler, Alexandrosz Czira, Ji-Hee Youn, Mia Malmenäs, Nancy A. Risebrough, Jatin Agarwal, Maria Nassim, Raj Sharma, Chris Compton, Claus F. Vogelmeier, MeiLan K. Han & David M. G. Halpin. (2022) Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis. Advances in Therapy 39:9, pages 3957-3978.
Crossref
Ashley Woodcock, Kai M. Beeh, Hironori Sagara, Simon Aumônier, Emmanuel Addo-Yobo, Javaid Khan, Jørgen Vestbo & Helen Tope. (2022) The environmental impact of inhaled therapy: making informed treatment choices. European Respiratory Journal 60:1, pages 2102106.
Crossref
Grammati Sarri. (2022) Can Real-World Evidence Help Restore Decades of Health Inequalities by Informing Health Care Decision-Making? Certainly, and Here is How. Frontiers in Pharmacology 13.
Crossref
Robert S. Epstein & J. Russell Teagarden. 2021. Pragmatic Randomized Clinical Trials. Pragmatic Randomized Clinical Trials 21 32 .
Saeed Noibi, Ahmed Mohy, Raef Gouhar, Fadel Shaker, Tamara Lukic & Hamdan Al-Jahdali. (2020) Asthma control factors in the Gulf Cooperation Council (GCC) countries and the effectiveness of ICS/LABA fixed dose combinations: a dual rapid literature review. BMC Public Health 20:1.
Crossref
Holly Tibble, James Lay-Flurrie, Aziz Sheikh, Rob Horne, Mehrdad A. Mizani & Athanasios Tsanas. (2020) Linkage of primary care prescribing records and pharmacy dispensing Records in the Salford Lung Study: application in asthma. BMC Medical Research Methodology 20:1.
Crossref
Jørgen Vestbo, Christer Janson, Javier Nuevo & David Price. (2020) Observational studies assessing the pharmacological treatment of obstructive lung disease: strengths, challenges and considerations for study design. ERJ Open Research 6:4, pages 00044-2020.
Crossref
Tetyana Kendzerska, Shawn D. Aaron, Teresa To, Chris Licskai, Matthew Stanbrook, Nicholas T. Vozoris, Mary-Ellen Hogan, Wan C. Tan, Jean Bourbeau & Andrea S. Gershon. (2019) Effectiveness and Safety of Inhaled Corticosteroids in Older Individuals with Chronic Obstructive Pulmonary Disease and/or Asthma. A Population Study. Annals of the American Thoracic Society 16:10, pages 1252-1262.
Crossref
Sally Worsley, Neil Snowise, David M.G. Halpin, Dawn Midwinter, Afisi S. Ismaila, Elaine Irving, Leah Sansbury, Maggie Tabberer, David Leather & Chris Compton. (2019) Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study design. ERJ Open Research 5:4, pages 00061-2019.
Crossref
Jeffrey S. Barrett & Penny M. Heaton. (2019) Real‐World Data: An Unrealized Opportunity in Global Health?. Clinical Pharmacology & Therapeutics 106:1, pages 57-59.
Crossref
Myrto Lee, Hoan Ly, Clemens C. Möller & Michael S. Ringel. (2019) Innovation in Regulatory Science Is Meeting Evolution of Clinical Evidence Generation. Clinical Pharmacology & Therapeutics 105:4, pages 886-898.
Crossref
Tobias Vogelmann. 2019. Market Access in der Medizintechnik. Market Access in der Medizintechnik 249 281 .
Giovanni Corrao & Anna Cantarutti. (2018) Building reliable evidence from real-world data: Needs, methods, cautiousness and recommendations. Pulmonary Pharmacology & Therapeutics 53, pages 61-67.
Crossref
Philippe Devillier, Marc Humbert, Alain Boye, Wolfgang Zachgo, Loretta Jacques, Carol Nunn, Sarah West, Andy Nicholls, Zeina Antoun, Luminita Spinu & Jean-Marie Grouin. (2018) Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting β2-agonists (ICS/LABA) in patients with uncontrolled asthma: An open-label, randomized, controlled trial. Respiratory Medicine 141, pages 111-120.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.